Interest has arisen in recent years in a remark ably consistent method for the transmission of leprosy (M. leprae) fr om man to mice which was first described by Shepard (1960 Shepard ( , 1962 . This finding was confirmed by other workers who used specimens of leprosy organisms obtained fr om patients in different countries (Rees, 1964; Pattyn and Janssens, 1965; Pattyn, 1965; Shepard and McRae, 1965) . Unfortunately the lesion produced was always microscopic. Briefly, in a high proportion of mice challenged in their foot pads with between 10 and 10 5 organisms, a mild form of infection was induced that developed very slowly and then regressed. In fact, multiplication only progressed to a limit of 10 6 _10 ' organisms for each foot and then stopped. However, inocula equal to this value (or even higher) did not undergo any increase.
The object of the present investigation was to examine the efficiency of the above technique as a routine method for determining anti microbial activity. In order to undertake this fully a wide choice of compounds was used including a few of uncertain or unknown effectiveness against human infection.
MATERIALS AND METHODS

Source of M. leprae
The specimens of M. leprae used in the present investigation were obtained fr om 2 different sources and each contained a fairly high pro portion of solid (viable) forms (Rees and Valentine, 1962) . Firstly, 3 specimens were extracted from biopsy material taken fr om untreated lepromatous patients in Malaya and these were supplied by the Medical Research Council through the courtesy of Dr. R. J. W. Rees (London, England) . Secondly, 2 specimens were isolated fr om previously infected mice and these were kindly sent by Dr. C. C. Shepard (Atlanta, U.S.A.). All the specimens were dispatched (on ice at O°C) by air to London and were used for challenge within 3 days of removal fr om the host. Specimens of M. leprae bacteria were supplied in the form of a suspension, these failed to grow when seeded on to Lowen stein-Jensens medium even after 6 months incubation at 37° or 32°C.
Animals
Albino mice (mostly males) of about 6 weeks of age and derived fr om the I.C.I. pathogen fr ee strain were used throughout.
Inoculation
The technique devised by Shepard was used to transfer leprosy to mice. Our own particular experimental methods for inoculation and subsequent harvesting of the organisms have been given in detail elsewhere (Gaugas, 1967) . In order to induce infection each mouse was challenged in both its hind foot pads with an inoculum of 5.0 X 10 3 organisms. The fresh human biopsy isolates were used as the first or subsequent mouse transfers. 
Drug Treatment
Administration of drugs was either by sub· cutaneous (s.c.) injection where each dose was usually dissolved in 0.2 ml. of sterile saline, or alternatively mixed in a powdered diet (i.e., orally). Th � regimen in the diet was based on a previous finding that mice ate 250 gm. jkg. of food every d ay regardless of the amount offered. Treatment was generally given for 5·7 days a week and lasted until the maximal level of organisms was reached in the foot pads of untreated control mice after 7·9 months. At this juncture treated mice were killed and the foot pad content of organisms was estimated separately for each mouse. Groups of 12-30 surviving mice were used to determine the effectiveness of each course of treatment usually against a single specimen of M. Zeprae.
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RESULTS
All the specimens of M. Zeprae behaved in a characteristic and predictable manner and this is illustrated (single example) by the growth curve in Fig 1. In order to obtain quantitative data on the infection it was necessary to con· tinue checking the foot pad yield of organisms monthly. Here, fr om a convenient inoculum of 5.0 X 10 ' (26% solid) organisms the limit of slightly above 10 · (24% solid) was reached after about 7t months. The infection, as expected, could be transferred fr om mouse to mouse. In contrast, a challenge dose of 10 · organisms failed to undergo multiplication. The Table summarises the effect of various antimicrobial compounds (3 loosely defined classes) against this particular form of infection. It also enables a direct comparison to be made Shepard (1966) 0.1% active, Rees (1965a) 0. 1 % (thrice weekly), Rees (1965a ) 0. 1 % complete, Shepard and Chang (19 64) 0.006% complete, Rees (1965a ) 0,1 % partial, Shepard and Chang (1964) 0. 1 % active, Rees (1965a ) 0. 1 % inactive, Shepard and Chang (1964) 0.1 % partial, Rees (1965b ) 0.1 % complete, Pattyn and Royackers (1965) 10 mg /mouse /day complete, Shepard (1964) 0.01 % complete, Shepard and Chang (1964) 0.06% complete, Shepard and Chang (1964) 2 mg /mouse /day complete, Shepard and Chang (1964) * Generally expressed as percentage of drug in diet.
with the results previously published by other workers who used the same screening technique. At first in our laboratory each compound was tested at its maximum tolerated dose (M.T.D.) for the mouse. Subsequently most of the compounds with a beneficial effect were tested with lower doses and only these later results are listed in the table. It can be seen that all the anti-leprosy drugs and all the anti-tuberculosis drugs we used prevented the multiplication of human leprosy organisms in the mouse. In addition, 2 broad spectrum antimicrobials cephaloridine and rifamycin also had the same effect. Previously thiambutosine was reported to be ineffective by Shepard and Chang (1964) . However, this was not at first confi rmed by Rees (1965a) but he later (1965b) observed irregular behaviour where some experiments resulted in complete inhibition and others resulted in partial or absence of activity. As he suggested, it is possible that this may be due to poor absorption in the mouse. In our own experiments complete inhibition was obtained for 2 specimens of M. leprae, one obtained from each of the above authors. In addition, sub cutaneous administration (bi-weekly) of the drug suspended in arachis oil was also found to be effective. Due to the above discrepancy the thiazoline derivative of this compound, SU 3068 Ciba, was also tested since it is more soluble. Here also complete inhibition was observed.
It is noteworthy that the lower dose of solapsone prevented bacterial multiplication in just over half the number of animals treated. This was regarded as a partial effect. Hence the minimal effective dose (M.E.D.) must be slightly above this value of 0.25 mg. /kg. body weight. This result correlates reasonably well with that for a related compound, dapsone, recently found by Shepard, McRae and Habas (1966) to have a complete effect even at the very low concentration of 0.0000 1 % in the diet. In fact, we found dapsone (25 mg. /kg.) effective even if given only for the first 2t months of the infection (although this result is not included in the Table) . It is interesting that the human leprosy organism is very susceptible to sul phones. In this respect it is unlike any other 228 Lep1"Osy Review pathogenic mycobacterium.
Information relevant to the pharmacology, toxicity and range of susceptible pathogens of the antimicrobials mentioned is readily avail able in the literature.
DISCUSSION
The mouse foot pad type of leprosy infection is easily cured from its inception by treating with a wide variety of antimicrobials, perhaps too easily in contrast to the disease in man. In human patients the problem is different since here infection, often with massive bacillary concentration, is already established before therapy begins. Moreover, the foot pad infection was too mild for assessing the value of combined drug therapy (if given for the duration of the infection). Nevertheless, the experimen tal in fection does provide the only means readily available to date for the screening of potential anti-leprosy drugs other than in human sub jects. This is because the organism responsible for leprosy in man cannot be grown on bacteriological media. One useful application of the mouse foot pad technique has already been demonstrated by Pettit and Rees (1964) and also by Adams and Waters (1966) where the occurrence of dapsone resistant M. leprae organisms from human patients (a total of 4 patients) was detected experimentally rather than by clinical observation. As a matter of interest the former patients then responded successfully to phenazine B 663 treatment (Pettit and Rees, 1966) .
As a safeguard before starting trials with a new drug on human patients it would be desirable to determine the M.E.D. required to stop multiplication of leprosy organisms in the mouse foot pad, and then compare this result with that of related compounds (if any). When such a list has been finally compiled it is possible that a relative pattern of antimicrobial effect against leprosy infection may emerge approach ing that already known for man. Owing to the long duration of the experiments and in the light of the experience gained it is recommended that extremely low doses of the compound should be given at the outset. Such a diversion from the routinely accepted method is probably due to the uniquely long generation time of about 26 days for M. leprae under these con ditions, as well as the mildness of the infection in the mouse.
Finally in the future, attempts must be made to induce a more massive type of leprosy infection in experimental animals. At present, the key to inducing a more progressive leprosy disease appears to be by the use of powerful immunosuppressive treatment. Recently some success has been achieved along these lines by Rees (1965 Rees ( , 1966 and also by Gaugas (1967 ) where thymectomy plus x-irradiation of adult mice markedly enhanced susceptibility to in fe ction in the foot pad. Advantages are to be found in a more reliable way of testing the effectiveness of anti-leprosy drugs in so far as this may be more discriminating. It would also allow the usefulness of combined therapy to be evaluated in the experimental animal.
SUMMARY
In the present investigation Shepard's original method for transmission of human leprosy (M. leprae) to the mouse was confirmed. As expected a very mild form of infection was induced. This model was used to test the effectiveness of antimicrobial therapy. At �ely arbitrary dose ranges treatment with dapsone, solapsone, sulphormethoxine, sulphadimeth---... oxine, B663(M) phenazine, thiacetazone, thiambutosine, SU 3068, capreomycin , isoniazid, oxydiazolone, PAS, streptomycin, streptovaricin, viomycin, cephaloridine and rifamycin com pletely suppressed the development of the mild infection, but tetracycline or morphazinamide had no inhibitory effect; gentamicin had only a partial ef fect. The suitability of this method for the screening of compounds is discussed.
